Do Medicare Part B Prescription Drug Modifications Harm Rural Hospitals?

Before following through with finalizing the modifications to the Medicare Part B drug prescription plan, CMS would take advantage from dealing the various uncertainties sent forward during the comment time period.

The intended modifications to the Medicare Part B prescription drug program are searching opposition among various medical agencies. The CMS (Centers for Medicare & Medicaid Services) will require addressing the issues in the latest proposed rule before sustaining with finalizing these modifications. The American Medical Group Association (AMGA) sent a letter to Centers for Medicare & Medicaid Services claiming its uncertainties with the renovations of the Medicare Part B prescription drug plan.

In accordance to a press release from AMGA, CMS should think about testing other choices of the average sales cost add-on payment as well as to make sure that Medicare beneficiaries have complete access to clinical decision information.